tamibarotene has been researched along with Chronic Illness in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ishiyama, K; Kasahara, K; Nakao, S; Ohkura, N; Saeki, K; Watanabe, S | 1 |
| De Caul, A; Else, KJ; Hurst, RJ; Kagechika, H; Little, MC | 1 |
| Azuma, M; Chen, L; Fujii, N; Fujiwara, H; Kobayashi, K; Kondo, E; Maeda, Y; Matsuoka, K; Nishimori, H; Tanaka, T; Tanimoto, M; Yagita, H | 1 |
| Fujiwara, SI; Inamoto, Y; Maeda, Y; Mori, Y; Nakamae, H; Nishimori, H; Ohashi, K; Sawa, M; Tanimoto, M | 1 |
1 trial(s) available for tamibarotene and Chronic Illness
| Article | Year |
|---|---|
An Open-labeled, Multicenter Phase II Study of Tamibarotene in Patients with Steroid-refractory Chronic Graft-versus-Host Disease.
Topics: Adrenal Cortex Hormones; Benzoates; Chronic Disease; Clinical Protocols; Graft vs Host Disease; Humans; Immunosuppressive Agents; Tetrahydronaphthalenes | 2016 |
3 other study(ies) available for tamibarotene and Chronic Illness
| Article | Year |
|---|---|
Tamibarotene for the Treatment of Bronchiolitis Obliterans Associated With Chronic Graft-vs-Host Disease.
Topics: Allografts; Benzoates; Biopsy; Bronchiolitis Obliterans; Chronic Disease; Follow-Up Studies; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Promyelocytic, Acute; Lung; Male; Middle Aged; Tetrahydronaphthalenes; Tomography, X-Ray Computed | 2019 |
The retinoic acid receptor agonist Am80 increases mucosal inflammation in an IL-6 dependent manner during Trichuris muris infection.
Topics: Animals; Benzoates; Cells, Cultured; Chemotaxis, Leukocyte; Chronic Disease; Disease Models, Animal; Inflammation Mediators; Interleukin-6; Intestinal Mucosa; Male; Mice; Mice, Inbred AKR; Mice, Inbred C57BL; Mice, Knockout; Receptors, Retinoic Acid; Tetrahydronaphthalenes; Trichuriasis; Trichuris; Up-Regulation | 2013 |
Programmed death-1 pathway in host tissues ameliorates Th17/Th1-mediated experimental chronic graft-versus-host disease.
Topics: Allografts; Animals; B7-H1 Antigen; Benzoates; Bone Marrow Transplantation; Chronic Disease; Disease Models, Animal; Female; Graft vs Host Disease; Mice; Mice, Inbred BALB C; Mice, Knockout; Programmed Cell Death 1 Ligand 2 Protein; Programmed Cell Death 1 Receptor; Tetrahydronaphthalenes; Th1 Cells; Th17 Cells | 2014 |